Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #97641 on Biotech Values
genisi
06/22/10 4:04 AM
#97678 RE: DewDiligence #97641
Is the 18.6% figure the average of all of the surveyed neurologists or the average of the 73% who think Gilenia will have an impact?
It will drop much more than that if the FDA approves generic Copaxone :- )